No preclinical rationale for IGF1R directed therapy in chondrosarcoma of bone

Author(s):
Peterse, E.F.P.; Cleven, A.H.G.; Jong, Y. de; Briaire-de Bruijn, I.; Fletcher, J.A.; Danen, E.H.J.; Cleton-Jansen, A.M.; Bovee, J.V.M.G. (0000-0003-1155-0481)
Published
2016
Publication type
Article / Letter to editor
ChondrosarcomaIGF1R signallingInsulin-like growth factorOSI-906Sarcoma
Date issued
2016-07-14
Language
English
Is part of
BMC Cancer
hdl
1887/112588
doi
10.1186/s12885-016-2522-8